Organon & Co. (NYSE: OGN) stock jumped 2.70% on Thursday to $19.79 against a previous-day closing price of $19.27. With 2.46 million shares changed hands, the volume of the stock remained heavier than its average volume of 2.09 million shares. During the session, the Drug Manufacturers – General company that operates in wider Healthcare sector, reached to the highest price of $19.85 whereas the lowest price it dropped to was $19.47. The 52-week range on OGN shows that it touched its highest point at $32.43 and its lowest point at $18.87 during that stretch. It currently has a 1-year price target of $31.00. With its current market cap of 5.10 billion, OGN has annualized dividend of $1.12 while the current yield stands at 5.66%. Beta for the stock currently stands at 0.79.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of OGN was up-trending over the past week, with a rise of 1.64%, but this was down by -14.92% over a month. Three-month performance dropped to -2.46% while six-month performance fell -8.04%. The stock lost -31.12% in the past year, while it has lost -29.14% so far this year. A look at the trailing 12-month EPS for OGN yields 2.95 with Next year EPS estimates of 4.59. For the next quarter, that number is 1.07. This implies an EPS growth rate of -32.40% for this year and 4.03% for next year. EPS is expected to decline by -5.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of -12.80%.
Float and Shares Shorts:
At present, 255.34 million OGN shares are outstanding with a float of 255.31 million shares on hand for trading. On Aug 30, 2023, short shares totaled 6.96 million, which was 2.72% higher than short shares on Jul 30, 2023. In addition to Mr. Kevin Ali as the firm’s CEO & Director, Mr. Matthew M. Walsh serves as its Exec. VP & CFO.
Through their ownership of 79.76% of OGN’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 50.49% of OGN, in contrast to 29.07% held by mutual funds. Shares owned by individuals account for 0.11%. As the largest shareholder in OGN with 11.96% of the stake, The Vanguard Group, Inc. holds 30,501,035 shares worth 30,501,035. A second-largest stockholder of OGN, Mawer Investment Management Ltd., holds 13,193,855 shares, controlling over 5.17% of the firm’s shares. SSgA Funds Management, Inc. is the third largest shareholder in OGN, holding 13,044,754 shares or 5.11% stake. With a 3.10% stake in OGN, the Vanguard Total Stock Market ETF is the largest stakeholder. A total of 7,915,904 shares are owned by the mutual fund manager. The Vanguard Small Cap Index Fund, which owns about 2.59% of OGN stock, is the second-largest Mutual Fund holder. It holds 6,615,789 shares valued at 145.42 million. Vanguard 500 Index Fund holds 2.40% of the stake in OGN, owning 6,113,128 shares worth 134.37 million.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on Jun 29, 2023, OGN reported revenue of $1.58B and operating income of $468.00M. The EBITDA in the recently reported quarter was $482.00M and diluted EPS was $0.92.
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for OGN since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With OGN analysts setting a high price target of $43.00 and a low target of $23.00, the average target price over the next 12 months is $30.00. Based on these targets, OGN could surge 117.28% to reach the target high and rise by 16.22% to reach the target low. Reaching the average price target will result in a growth of 51.59% from current levels.
EPS: Estimates vs Actual
It is also common to use earnings estimates to evaluate a firm’s growth potential and to determine trading strategy.
Summary of Insider Activity:
Insiders traded OGN stock several times over the past three months with 2 Buys and 2 Sells. In these transactions, 35,242 shares were bought while 15,424 shares were sold. The number of buy transactions has increased to 41 while that of sell transactions has risen to 41 over the past year. The total number of shares bought during that period was 225,397 while 94,715 shares were sold.